Scarica l'app Stockscreener
12.53
11.28%
1.27
Precedente Chiudi:
$11.26
Aprire:
$11.34
Volume 24 ore:
293.44K
Relative Volume:
0.84
Capitalizzazione di mercato:
$420.93M
Reddito:
-
Utile/perdita netta:
$-47.20M
Rapporto P/E:
-8.0049
EPS:
-1.5653
Flusso di cassa netto:
$-43.65M
1 W Prestazione:
+4.85%
1M Prestazione:
-3.91%
6M Prestazione:
+38.91%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$11.34
$12.62
Intervallo di 1 settimana:
$10.11
$12.64
Portata 52W:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Nome
Mbx Biosciences Inc
Settore
Industria
Telefono
(317) 989-3100
Indirizzo
11711 N. MERIDIAN STREET, CARMEL
Confronta MBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
12.53 | 378.27M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Iniziato | Mizuho | Outperform |
| 2025-07-16 | Iniziato | Oppenheimer | Outperform |
| 2025-04-10 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-10-08 | Iniziato | Guggenheim | Buy |
| 2024-10-08 | Iniziato | JP Morgan | Overweight |
| 2024-10-08 | Iniziato | Jefferies | Buy |
| 2024-10-08 | Iniziato | Stifel | Buy |
Mostra tutto
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Recommendation of “Buy” by Analysts - Defense World
MBX Biosciences Inc. recovery potential after sell offSector Rotation Strategy for Smart Traders - Newser
Using economic indicators to assess MBX Biosciences Inc. potentialSector-Wise Equity Performance Trend Forecast - Newser
MBX Biosciences Reports Progress and Financial Stability - TipRanks
Tools to assess MBX Biosciences Inc.’s risk profileTriple Digit Gain Opportunity Watchlist - Newser
Can a trend reversal in MBX Biosciences Inc. lead to recoverySummary of Trade Cycles in 5-Year Range - Newser
How to use a screener to detect MBX Biosciences Inc. breakoutsReal Time Screener for Growth Trades - Newser
Technical signs of recovery in MBX Biosciences Inc.Free Reliable Investment Entry Point Signals - Newser
Can trapped investors hope for a rebound in MBX Biosciences Inc.Free Market Surge Signal for Swing Traders - Newser
Applying big data sentiment scoring on MBX Biosciences Inc.Free ROI Driven Equity Selection With Safety - Newser
What’s next for MBX Biosciences Inc. stock priceFree Low Volatility Stable Growth Picks - Newser
How does MBX Biosciences Inc. compare to its peers3x ROI Investment Watch - thegnnews.com
MBX Biosciences (NYSE:MBX) Earns Outperform Rating from Analysts at Mizuho - MarketBeat
Technical analysis overview for MBX Biosciences Inc. stockMachine Learning Intraday Signal Forecast - Newser
Is MBX Biosciences Inc. forming a reversal patternSwing Trade Picks with High Potential - Newser
MBX Biosciences Inc. Forms Bullish Flag — Upside AheadBreakout Entry Signal Confirmation Tool Used - beatles.ru
MBX Biosciences (NYSE:MBX) Research Coverage Started at Mizuho - Defense World
Mbx Biosciences (MBX) Q2 Loss Widens 22% - Nasdaq
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
MBX Biosciences Reveals Triple Clinical Trial Progress, Secures 2-Year Cash Runway With $224M - Stock Titan
Volatility clustering patterns for MBX Biosciences Inc.Free Chart Breakout Buy Signal Detection - Newser
How MBX Biosciences Inc. stock performs during market volatilitySmart Entry Signals for Active Traders - Newser
Mizuho Securities Initiates MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $38 - 富途牛牛
Analyst Upgrades and Initiations for Tuesday: Lionsgate Studios, MBX Biosciences, D-Wave Quantum, APA Corporation, and Quince Therapeutics - AInvest
This Lionsgate Studios Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Mizuho Initiates MBX Biosciences at Outperform - MarketScreener
Mizuho initiates MBX Biosciences stock with Outperform rating on promising pipeline - Investing.com Nigeria
MBX Biosciences initiated with an Outperform at Mizuho - TipRanks
RSI Crosses Above 30 for MBX Biosciences Inc. — Reversal in SightSector Rotation Based Trading Opportunities Identified - metal.it
What is MBX Biosciences Inc. company’s growth strategyCapitalize on fast-moving stock trends - Jammu Links News
What is the dividend policy of MBX Biosciences Inc. stockInvest smarter with advanced market data - Jammu Links News
When is MBX Biosciences Inc. stock expected to show significant growthFree High-Return Strategy Alerts - Jammu Links News
What are the latest earnings results for MBX Biosciences Inc.Get exclusive access to professional stock picks - Jammu Links News
Why is MBX Biosciences Inc. stock attracting strong analyst attentionDiscover hidden gems in the stock market - Jammu Links News
How does MBX Biosciences Inc. compare to its industry peersTremendous wealth creation - Jammu Links News
What makes MBX Biosciences Inc. stock price move sharplyUnlock powerful stock screening tools - Jammu Links News
Is MBX Biosciences Inc. a good long term investmentUnprecedented profit potential - Jammu Links News
What are MBX Biosciences Inc. company’s key revenue driversGet expert insights on market-moving stocks - Jammu Links News
Mbx Biosciences Inc Azioni (MBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):